Need more information about our assay development process, or to discuss our current assay offerings? Simply use the channels below to get in touch with the Inaphaea team.

Meet us at these upcoming events in 2025

• Charles River Biotech Symposium, 7-10 September, Calsbad, USA
  • Mark Eccleston will be speaking about CLX001 – A Novel Oncolytic Peptide for Triple Negative Breast Cancer Therapy, and will be joining the Peptide Drug Hunting Consortium’s (PDHC) panel
• Medilink Midlands Innovation Day, 17 September, Aston Villa Football Club, UK
  • Mark will be chairing the Innovation panel session, which is designed to showcase cutting-edge developments from leading companies in a dynamic, fast-paced format. The audience will hear pitching slots from a number of businesses showcasing their innovation.
• Oxford Global Discovery & Development US 2025, 2-3 October, San Diego, USA
  • Mark will be speaking about the Formulation of CLX-001, a next generation oncolytic peptide for cancer therapy
• IQ Hub European Drug Delivery Summit, 8-9 October, Frankfurt, Germany
  • Mark will be a panel member for: PRECISION MEDICINE: ENCAPSULATION TECHNIQUES FOR TARGETED DRUG DELIVERY